As of Apr 29
| -1.19 / -2.54%|
The 3 analysts offering 12-month price forecasts for ANI Pharmaceuticals Inc have a median target of 50.00, with a high estimate of 51.00 and a low estimate of 49.00. The median estimate represents a +9.96% increase from the last price of 45.47.
The current consensus among 3 polled investment analysts is to Buy stock in ANI Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.